Compound Evidence File
#EC-2026-0399
RIPEX 225 (TRA/Mast P/Test P)
Filed under Injectable Oils. The bureau holds 131 laboratory returns for this compound from 51 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
51 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Mar 2026 | 15 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Apr 2026 | 18 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 4 Mar 2026 | 10 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Apr 2026 | 13 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Jan 2026 | 8 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 12 May 2026 | 14 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Mar 2026 | 8 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Feb 2026 | 26 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 27 Jan 2026 | 11 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 10.0 | 10.0 | 14 Mar 2026 | 27 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 21 May 2026 | 12 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 18 Feb 2026 | 2 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 1 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 28 Feb 2026 | 11 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 12 May 2026 | 6 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 28 Dec 2025 | 11 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 11 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 9.9 | 17 Feb 2026 | 5 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Mar 2026 | 14 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Jul 2026 | 20 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Jun 2026 | 25 Jun 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 9.1 | 8.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 8.5 | 8.5 | 8.5 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.4 | 7.1 | 9.6 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.3 | 6.9 | 9.5 | 25 May 2026 | 25 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 8.2 | 8.2 | 8.2 | 13 Feb 2025 | 13 Feb 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 7.8 | 7.3 | 8.3 | 24 May 2026 | 24 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 7.8 | 6.2 | 9.4 | 6 May 2025 | 26 Jan 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 7.3 | 6.4 | 7.8 | 24 May 2026 | 24 May 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 7.2 | 7.2 | 7.2 | 21 May 2025 | 21 May 2025 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 7.0 | 7.0 | 7.0 | 9 Jun 2025 | 9 Jun 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 3 | 6.9 | 6.5 | 7.1 | 17 Dec 2024 | 24 May 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 3 | 6.7 | 5.9 | 7.7 | 24 Apr 2025 | 19 Jan 2026 |
| OupeptideCASE #VI-2026-0435 | X | 3 | 6.6 | 5.9 | 7.6 | 11 Jun 2025 | 21 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 | 3 Jul 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 | 25 Apr 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 5 | 6.1 | 4.6 | 7.3 | 3 Jun 2025 | 23 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 1 | 5.6 | 5.6 | 5.6 | 7 May 2025 | 7 May 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 5.5 | 5.0 | 6.0 | 20 Jun 2025 | 21 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 | 28 Mar 2025 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 4.9 | 4.9 | 4.9 | 13 Jun 2025 | 13 Jun 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 1 | 4.0 | 4.0 | 4.0 | 3 Jul 2025 | 3 Jul 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 3.8 | 3.8 | 3.8 | 14 Jan 2025 | 14 Jan 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 3.5 | 3.5 | 3.5 | 7 May 2025 | 7 May 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 2.2 | 2.2 | 2.2 | 6 May 2025 | 6 May 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 2.0 | 2.0 | 2.0 | 6 May 2025 | 6 May 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jun 2025 | 3 Jun 2025 |
Open any subject to view the batch-level evidence for RIPEX 225 (TRA/Mast P/Test P) alone.